Patent 7745128 was granted and assigned to Globeimmune, Inc. on June, 2010 by the United States Patent and Trademark Office.
Disclosed are newly discovered Ras mutations and combinations of mutations, proteins and peptides and fusion proteins containing these mutations, nucleic acid molecules encoding such proteins, peptides, and fusion proteins, and a variety of tools and diagnostic, therapeutic, and screening methods associated with the use of such mutations.